Page 325 - Vitamin D and Cancer

312 M. Fakih et al.

58. Kampman E et al (2000) Calcium, vitamin D, sunshine exposure, dairy products and colon
cancer risk (United States). Cancer Causes Control 11(5):459–466
59. Terry P et al (2002) Dietary calcium and vitamin D intake and risk of colorectal cancer:
a prospective cohort study in women. Nutr Cancer 43(1):39–46
60. Ferraroni M et al (1994) Selected micronutrient intake and the risk of colorectal cancer. Br
J Cancer 70(6):1150–1155
61. Peters RK et al (1992) Diet and colon cancer in Los Angeles County, California. Cancer
Causes Control 3(5):457–473
62. Pietinen P et al (1999) Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer
Causes Control 10(5):387–396
63. Gorham ED et al (2005) Vitamin D and prevention of colorectal cancer. J Steroid Biochem
Mol Biol 97(1–2):179–194
64. Yaylim-Eraltan I et al (2007) Investigation of the VDR gene polymorphisms association with
susceptibility to colorectal cancer. Cell Biochem Funct 25(6):731–737
65. Ingles SA et al (2001) Vitamin D receptor polymorphisms and risk of colorectal adenomas
(United States). Cancer Causes Control 12(7):607–614
66. Peters U et al (2004) Circulating vitamin D metabolites, polymorphism in vitamin D receptor,
and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 13(4):546–552
67. Parisi E et al (2008) Vitamin D receptor levels in colorectal cancer Possible role of BsmI
polymorphism. J Steroid Biochem Mol Biol [Epub ahead of print]
68. Hubner RA et al (2008) Dairy products, polymorphisms in the vitamin D receptor gene and
colorectal adenoma recurrence. Int J Cancer 123(3):586–593
69. Thomas MG et al (1999) Vitamin D receptor expression in colorectal cancer. J Clin Pathol
52(3):181–183
70. Meggouh F et al (1990) Evidence of 1, 25-dihydroxyvitamin D3-receptors in human digestive
mucosa and carcinoma tissue biopsies taken at different levels of the digestive tract, in 152
patients. J Steroid Biochem 36(1–2):143–147
71. Cross HS et al (1996) Vitamin D receptor and cytokeratin expression may be progression
indicators in human colon cancer. Anticancer Res 16(4B):2333–2337
72. Evans SR et al (1998) Vitamin D receptor expression as a predictive marker of biological
behavior in human colorectal cancer. Clin Cancer Res 4(7):1591–1595
73. Matusiak D et al (2005) Expression of vitamin D receptor and 25-hydroxyvitamin
D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol
Biomarkers Prev 14(10):2370–2376
74. Murillo G et al (2007) Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer.
J Steroid Biochem Mol Biol 103(3–5):763–767
75. Kallay E et al (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation
and oxidative stress. Food Chem Toxicol 40(8):1191–1196
76. Bises G et al (2004) 25-Hydroxyvitamin D3-1alpha-hydroxylase expression in normal and
malignant human colon. J Histochem Cytochem 52(7):985–989
77. Kallay E et al (2001) Characterization of a vitamin D receptor knockout mouse as a model of
colorectal hyperproliferation and DNA damage. Carcinogenesis 22(9):1429–1435
78. Huerta S et al (2002) 1Alpha, 25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load
in the Apc(min) Mouse. Cancer Res 62(3):741–746
79. Makishima M et al (2002) Vitamin D receptor as an intestinal bile acid sensor. Science
296(5571):1313–1316
80. Holt PR et al (2002) Colonic epithelial cell proliferation decreases with increasing levels of
serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 11(1):113–119
81. Holt PR et al (2006) Calcium plus vitamin D alters preneoplastic features of colorectal ade-
nomas and rectal mucosa. Cancer 106(2):287–296
82. Niv Y et al (1999) In colorectal carcinoma patients, serum vitamin D levels vary according to
stage of the carcinoma. Cancer 86(3):391–397
83. Sunga A et al (2008) Chemotherapy is linked to severe vitamin D deficiency in patients with
colorectal cancer. Gastrointestinal Cancers Symposium, Abstract 297